Al-Razi Medical Company (TADAWUL: 9572)

Al-Razi Medical Company Income Statement

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	61.99	61.33	52.39	45.19
Revenue Growth (YoY)	5.33%	17.07%	15.95%	-
Cost of Revenue	45.66	44.03	36.42	32.23
Gross Profit	16.34	17.3	15.97	12.95
Selling, General & Admin	15.73	15.92	13.39	10.53
Operating Expenses	15.73	15.93	13.4	10.53
Operating Income	0.61	1.37	2.57	2.42
Interest Expense	-0.53	-0.48	-0.3	-0.37
Other Non Operating Income (Expenses)	0.34	0.18	0.15	0.48
EBT Excluding Unusual Items	0.43	1.08	2.43	2.53
Gain (Loss) on Sale of Assets	0.01	0.01	-	-
Pretax Income	0.44	1.09	2.43	2.53
Income Tax Expense	0.35	0.4	0.41	0.37
Net Income	0.09	0.69	2.01	2.16
Net Income to Common	0.09	0.69	2.01	2.16
Net Income Growth	-95.60%	-65.95%	-6.87%	-
Shares Outstanding (Basic)	2	2	2	2
Shares Outstanding (Diluted)	2	2	2	2
EPS (Basic)	0.06	0.45	1.33	1.42
EPS (Diluted)	0.06	0.45	1.33	1.42
EPS Growth	-95.60%	-65.95%	-6.87%	-
Free Cash Flow	-0.09	1	-0.64	-2.82
Free Cash Flow Per Share	-0.06	0.66	-0.42	-1.86
Gross Margin	26.35%	28.21%	30.49%	28.67%
Operating Margin	0.98%	2.24%	4.91%	5.36%
Profit Margin	0.14%	1.12%	3.84%	4.79%
Free Cash Flow Margin	-0.14%	1.63%	-1.22%	-6.25%
EBITDA	2.14	2.8	3.64	3.32
EBITDA Margin	3.45%	4.56%	6.94%	7.34%
D&A For EBITDA	1.53	1.43	1.06	0.9
EBIT	0.61	1.37	2.57	2.42
EBIT Margin	0.98%	2.24%	4.91%	5.36%
Effective Tax Rate	79.51%	36.82%	16.94%	14.61%
Advertising Expenses	-	0.27	0.09	0.08

Source: S&P Capital IQ. Standard template. Financial Sources.